TS
BTTX

Thomas Steyer’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Thomas Steyer’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-330,619
Closed -$357K – 181
2023
Q2 		$357K Sell
330,619
-368,423
-53% -$356K ﹤0.01% 134
2023
Q1 		$509K Sell
699,042
-114,514
-14% -$135K ﹤0.01% 149
2022
Q4 		$911K Sell
813,556
-186,444
-19% -$275K 0.01% 175
2022
Q3 		$1.76M Hold
1,000,000
– – 0.01% 208
2022
Q2 		$1.56M Sell
1,000,000
-147,400
-13% -$247K 0.01% 210
2022
Q1 		$2.27M Sell
1,147,400
-202,600
-15% -$700K 0.01% 213
2021
Q4 		$6.28M Buy
+1,350,000
New +$11.1M 0.03% 171

Other funds holding BTTX

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Thomas Steyer's BTTX Position: Q3 2023 in Review

Thomas Steyer sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q3 2023, closing a stake of 330,619 shares — an estimated $357K sold.

Thomas Steyer first reported a position in BTTX in Q4 2021 and held it in 7 quarters. The position peaked at $6.28M in Q4 2021. 18 funds tracked by Wall St. Rank hold BTTX as of Q3 2023.

  • Thomas Steyer reported no remaining Better Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Thomas Steyer sold 330,619 Better Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $357K.
  • Thomas Steyer first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Thomas Steyer's Better Therapeutics, Inc. Common Stock position peaked at $6.28M in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.